We have been fans of DNB (OTCPK:DNHBY) (OTCPK:DNBHF) for quite a long time now. It is the largest financial services group in Norway, and, more importantly, one of the safest banks in the world. A little less than a year ago, we said that DNB was offering a ‘once-in-a-lifetime’ buying opportunity. Our high-conviction contrarian call was based on the fact that DNB was trading at a very undemanding valuation, despite having a double-digit RoE, strong capital ratios and a 6% dividend yield. We also argued that market fears over the banks asset quality issues were overdone as DNB has a prudent risk management approach. Since that, DNB’s shares have rallied by 55%. And that does not include the stock’s generous dividends.
Best Safest Stocks To Watch For 2019: Orbital ATK, Inc.(OA)
- [By Lisa Levin]
Defense giant Northrop Grumman Corporation (NYSE: NOC) confirmed Monday it will buy Orbital ATK Inc (NYSE: OA), the maker of the Pegasus rocket and a vast array of other aerospace and defense systems, in a $9.2 billion deal.
- [By Rich Smith]
On one particularly big news day, April 28, the DSCA announced that it has notified Congress of no fewer than seven separate pending arms sales that it plans to push through. These deals are aiming to sell:
110 radar-seeking air-to-ground “HARM” missiles to Australia, generating sales of $137.6 million for prime contractors Orbital ATK (NYSE:OA) and Raytheon (NYSE:RTN). Four P-8A Poseidonsubmarine-hunting jet aircraft to New Zealand — a $1.46 billion payday for Boeing (NYSE:BA). 13 76 mm cannonfor installation aboard Israeli Navy SA’AR 4.5 and SA’AR 6 Missile Patrol Boats at a purchase price of $440 million. (Italian firm Leonardo S.p.a.’s DRS North America subsidiary will be the contractor on that one.) Nine Bell 429light utility helicopters to Slovakia, yielding sales of $150 million for Textron (NYSE:TXT). And five CH-47D Chinookhelicopters, sold out of U.S. government surplus to Greece for $80 million.
Also included in the DSCA’s list of pending contracts are two directed toward the NATO Support and Procurement Agency, specifically:
- [By Jim Robertson]
Last Monday, U.S. defense contractor Northrop Grumman Corporation (NYSE: NOC) announced it would buy Orbital ATK Inc (NYSE: OA), a direct Aerojet Rocketdyne competitor,for about $7.8 billion (a 22% premium to Orbital’s Friday close) in a deal thatwill give it greater access to lucrative government contracts and expand its arsenal of missile defense systems and space rockets. While Northrop already has a significant presence in payloads, it has not had launcher capability, an area that Orbital brings for both space and missile defense. Orbital also has contracts with NASA and the U.S. Army. The all-cash transaction is the biggest in the defense sector in two years and comes ahead of planned upgrades of U.S. ballistic systems (as the saber rattling by North Korea continues), which are expected to drive demand for missiles.
- [By Rich Smith]
Now consider that as of the last report, Americans owned 265 million guns — but fewer than 1 million silencers. That’s a huge market that American Outdoor Brands and Sturm, Ruger would love to sell into. Easing restrictions on silencer sales could have follow-on effects, too. Granting easier access to suppressors could reduce noise complaints at open-air shooting ranges, making it easier for such businesses to open, which would attract more customers, resulting in more ammunition being used, resulting in more ammunition being sold, resulting in more sales (and profits) for ammo makers such as Olin Corp (NYSE:OLN), Vista Outdoor (NYSE:VSTO), and Orbital ATK (NYSE:OA).
- [By Rich Smith]
Orbital ATK (NYSE:OA) occupies a charmed space in the U.S. market for putting satellites in, er, space.
At one end of the space launch continuum, you have United Launch Alliance, whose Delta IV Heavy launch vehicle, developed by Boeing (NYSE:BA), can put a payload massing in excess of 28 tonsinto orbit in a single launch — at a cost of $350 million.At the other end, new space start-ups like Vector Space are promising to launch a new generation of small satellites into low-earth orbit for prices as little as $2 million a shot. But what about the middle?
- [By Rich Smith]
Much of this was based on educated guesswork, however, as we extrapolated what we knew about the finances at SpaceX rivalsBoeing(NYSE:BA),Lockheed Martin(NYSE:LMT),Orbital ATK(NYSE:OA), andAirbus(NASDAQOTH:EADSY), and applied it to what wethoughtthat might mean for SpaceX’s own finances. It would have been a whole lot easier to just take a good hard look at SpaceX’s own financial documents, and get the answers straight from the source.
Best Safest Stocks To Watch For 2019: ANI Pharmaceuticals, Inc.(ANIP)
- [By Joseph Griffin]
Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.
Best Safest Stocks To Watch For 2019: Monsanto Company(MON)
- [By ]
Bayer AG (BAYRY) also rose 4.13% to 97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.
- [By Maxx Chatsko]
BeforeBayer(NASDAQOTH: BAYRY)arrived onto the scene, I viewedMonsanto(NYSE: MON)as an intriguing growth stock. It has a rich history of delivering value to shareholders and continues to hold a dominant technological edge over key competitors in crop protection products, seeds, and traits. While little has changed its promising pipeline and portfolio, the pending acquisition throws a wrench in anyone’s plans to start or add to a position. Uncertainty stemming from the merger provides several terrible reasons to buy Monsanto at this time.
- [By Chris Lange]
Monsanto Co. (NYSE: MON) is expected to share its most recent quarterly numbers first thing Thursday. Analysts are looking for $0.42 in earnings per share (EPS) and $2.77 billion in revenue. Shares were last seen at $116.78 apiece, in a 52-week range of $104.77 to $122.80. The consensus price target is $125.18.
- [By Shanthi Rexaline]
Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers
Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.
- [By Logan Wallace]
Global X Management Co. LLC trimmed its stake in shares of Monsanto (NYSE:MON) by 6.8% during the first quarter, HoldingsChannel.com reports. The fund owned 11,141 shares of the basic materials company’s stock after selling 818 shares during the period. Global X Management Co. LLC’s holdings in Monsanto were worth $1,300,000 as of its most recent SEC filing.
- [By Max Byerly]
Monsanto (NYSE:MON) was downgraded by equities research analysts at Argus from a “buy” rating to a “sell” rating in a research note issued to investors on Monday, The Fly reports.
Best Safest Stocks To Watch For 2019: MCBC Holdings, Inc.(MCFT)
- [By Lisa Levin] Gainers
The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
Best Safest Stocks To Watch For 2019: Starbucks Corporation(SBUX)
- [By Seth McNew]
Some of what Chipotle is doing comes from Starbucks’ (NASDAQ:SBUX) playbook. The coffee company was a trailblazer in creating a digital and mobile strategy that has truly transformed the customer experience and added to Starbucks’ bottom line. Its app, which features a mobile wallet-style system of stored preferences and the ability to order ahead to pick up your drink without waiting in line, now has more than 13 million active users, and the company has pointed to its digital growth many times as a boost to its comparable-store sales and margin growth. Mobile payments now make up one-quarter of all Starbucks transactions.
- [By Logan Wallace]
Cypress Wealth Services LLC trimmed its holdings in shares of Starbucks (NASDAQ:SBUX) by 7.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,248 shares of the coffee company’s stock after selling 1,533 shares during the quarter. Cypress Wealth Services LLC’s holdings in Starbucks were worth $1,056,000 at the end of the most recent quarter.
- [By Motley Fool Staff]
Barker: Yeah, it’s a little jarring, “McDonald’s restaurants,” because I guess the image I have, in my head at least, of a restaurant is a little bit more of a sit-down experience than the counter experience. This is not a shot at McDonald’s, although we could go in that direction if you have a good line or something, but I feel the same way about Starbucks(NASDAQ:SBUX) also included in the restaurant category.
- [By Lisa Levin] Gainers
Gramercy Property Trust (NYSE: GPT) rose 13.4 percent to $27.01 in pre-market trading after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
Warrior Met Coal, Inc. (NYSE: HCC) rose 9.1 percent to $30 in pre-market trading after climbing 5.61 percent on Friday.
Check-Cap Ltd. (NASDAQ: CHEK) rose 6.2 percent to $4.83 in pre-market trading after falling 48.35 percent on Friday.
Ceragon Networks Ltd. (NASDAQ: CRNT) rose 6 percent to $2.85 in pre-market trading after climbing 1.89 percent on Friday.
Ctrip.com International, Ltd. (NASDAQ: CTRP) rose 4.8 percent to $43.15 in pre-market trading.
G1 Therapeutics, Inc. (NASDAQ: GTHX) rose 3.2 percent to $44.00 in pre-market trading after climbing 6.92 percent on Friday.
Synchrony Financial (NYSE: SYF) rose 3.2 percent to $33.68 in pre-market trading after gaining 2.03 percent on Friday.
Starbucks Corporation (NASDAQ: SBUX) rose 3.1 percent to $59.45 in pre-market trading. Nestle announced plans to acquire rights to market, sell and distribute Starbucks Brands.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- [By Chris Lange]
Starbucks Corp. (NASDAQ: SBUX) is expected to report its most recent quarterly results on Thursday as well. The consensus estimates call for $0.55 in EPS and $5.75 billion in revenue. Shares closed trading at $57.98 on Friday, in a 52-week range of $50.84 to $64.87. The consensus price target is $66.52.